{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:54Z","timestamp":1792782534490,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of the Fundamental Research Funds for Soochow University","award":["No. H230337"],"award-info":[{"award-number":["No. H230337"]}]},{"name":"the Open Research Fund of Suzhou Key Lab of Multi-modal Data Fusion and Intelligent Healthcare","award":["No. 25SZZD05"],"award-info":[{"award-number":["No. 25SZZD05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04174-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T07:00:04Z","timestamp":1759129204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differentiation and mitochondrial metabolic characteristics of CD8+ T cells in malignant ascites of epithelial ovarian cancer and their correlation with estrogen signaling"],"prefix":"10.1007","volume":"74","author":[{"given":"Zouyu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"1","key":"4174_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4174_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"MR Brett","year":"2017","unstructured":"Brett MR, Jennifer BP, Thomas AS, Brett MR, Jennifer BP, Thomas AS (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14(1):9\u201332. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0084","journal-title":"Cancer Biol Med"},{"key":"4174_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00256","author":"N Ahmed","year":"2013","unstructured":"Ahmed N, Stenvers KL (2013) Getting to know Ovarian Cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2013.00256","journal-title":"Front Oncol"},{"issue":"17","key":"4174_CR4","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/cancers13174318","volume":"13","author":"BP Rickard","year":"2021","unstructured":"Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA et al (2021) Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response. Cancers 13(17):4318. https:\/\/doi.org\/10.3390\/cancers13174318","journal-title":"Cancers"},{"issue":"10","key":"4174_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003329","volume":"9","author":"R Muthuswamy","year":"2021","unstructured":"Muthuswamy R, McGray AR, Battaglia S, He W, Miliotto A, Eppolito C et al (2021) CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J Immunother Cancer 9(10):e003329. https:\/\/doi.org\/10.1136\/jitc-2021-003329","journal-title":"J Immunother Cancer"},{"key":"4174_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.102602","volume":"51","author":"R Liu","year":"2020","unstructured":"Liu R, Hu R, Zeng Y, Zhang W, Zhou H-H (2020) Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: a gene expression-based computational study. EBioMedicine 51:102602. https:\/\/doi.org\/10.1016\/j.ebiom.2019.102602","journal-title":"EBioMedicine"},{"issue":"12","key":"4174_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3290","volume":"3","author":"EL Goode","year":"2017","unstructured":"Ovarian Tumor Tissue Analysis C, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W et al (2017) Dose-Response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncol 3(12):e173290. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3290","journal-title":"JAMA Oncol"},{"issue":"5","key":"4174_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1424672","volume":"7","author":"S Lieber","year":"2018","unstructured":"Lieber S, Reinartz S, Raifer H, Finkernagel F, Dreyer T, Bronger H et al (2018) Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells. Oncoimmunology 7(5):e1424672. https:\/\/doi.org\/10.1080\/2162402X.2018.1424672","journal-title":"Oncoimmunology"},{"issue":"1","key":"4174_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41467-020-15315-8","volume":"11","author":"A F\u00e4rkkil\u00e4","year":"2020","unstructured":"F\u00e4rkkil\u00e4 A, Gulhan DC, Casado J, Jacobson CA, Nguyen H, Kochupurakkal B et al (2020) Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer. Nat Commun 11(1):1459. https:\/\/doi.org\/10.1038\/s41467-020-15315-8","journal-title":"Nat Commun"},{"key":"4174_CR10","doi-asserted-by":"publisher","first-page":"1111061","DOI":"10.3389\/fphar.2023.1111061","volume":"14","author":"S Zeng","year":"2023","unstructured":"Zeng S, Liu D, Yu Y, Zou L, Jin X, Liu B, Liu L (2023) Efficacy and safety of PD-1\/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: a systematic review and a meta-analysis. Front Pharmacol 14:1111061. https:\/\/doi.org\/10.3389\/fphar.2023.1111061","journal-title":"Front Pharmacol"},{"issue":"1","key":"4174_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-immunol-101819-082015","volume":"39","author":"EM Steinert","year":"2021","unstructured":"Steinert EM, Vasan K, Chandel NS (2021) Mitochondrial metabolism regulation of T cell-mediated immunity. Annu Rev Immunol 39(1):395\u2013416. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-082015","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4174_CR12","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Kn\u00f6pper K et al (2023) Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming. Nat Commun 14(1):6858. https:\/\/doi.org\/10.1038\/s41467-023-42634-3","journal-title":"Nat Commun"},{"issue":"1","key":"4174_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12943-024-02175-9","volume":"23","author":"M-Q Yang","year":"2024","unstructured":"Yang M-Q, Zhang S-L, Sun L, Huang L-T, Yu J, Zhang J-H et al (2024) Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells. Mol Cancer 23(1):260. https:\/\/doi.org\/10.1186\/s12943-024-02175-9","journal-title":"Mol Cancer"},{"issue":"19","key":"4174_CR14","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.3390\/cancers13195011","volume":"13","author":"M Gjorgoska","year":"2021","unstructured":"Gjorgoska M, Ri\u017ener TL (2021) Estrogens and the Schr\u00f6dinger\u2019s cat in the ovarian tumor microenvironment. Cancers 13(19):5011. https:\/\/doi.org\/10.3390\/cancers13195011","journal-title":"Cancers"},{"issue":"1","key":"4174_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-021-02003-w","volume":"21","author":"T Wang","year":"2021","unstructured":"Wang T, Jin J, Qian C, Lou J, Lin J, Xu A et al (2021) Estrogen\/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. Cancer Cell Int 21(1):295. https:\/\/doi.org\/10.1186\/s12935-021-02003-w","journal-title":"Cancer Cell Int"},{"issue":"6754","key":"4174_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708\u2013712. https:\/\/doi.org\/10.1038\/44385","journal-title":"Nature"},{"issue":"3","key":"4174_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00262-014-1636-6","volume":"64","author":"J Landskron","year":"2015","unstructured":"Landskron J, Helland \u00d8, Torgersen KM, Aandahl EM, Gjertsen BT, Bj\u00f8rge L, Task\u00e9n K (2015) Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. Cancer Immunol Immunother 64(3):337\u2013347. https:\/\/doi.org\/10.1007\/s00262-014-1636-6","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"4174_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC et al (2016) The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45(2):374\u2013388. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.009","journal-title":"Immunity"},{"issue":"9","key":"4174_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41590-020-0725-2","volume":"21","author":"SA Vardhana","year":"2020","unstructured":"Vardhana SA, Hwee MA, Berisa M, Wells DK, Yost KE, King B et al (2020) Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol 21(9):1022\u20131033. https:\/\/doi.org\/10.1038\/s41590-020-0725-2","journal-title":"Nat Immunol"},{"issue":"1","key":"4174_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"S-F Wang","year":"2023","unstructured":"Wang S-F, Tseng L-M, Lee H-C (2023) Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 30(1):61. https:\/\/doi.org\/10.1186\/s12929-023-00956-w","journal-title":"J Biomed Sci"},{"issue":"6","key":"4174_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41590-022-01219-w","volume":"23","author":"D Zehn","year":"2022","unstructured":"Zehn D, Thimme R, Lugli E, De Almeida GP, Oxenius A (2022) \u2018Stem-like\u2019 precursors are the fount to sustain persistent CD8+ T cell responses. Nat Immunol 23(6):836\u2013847. https:\/\/doi.org\/10.1038\/s41590-022-01219-w","journal-title":"Nat Immunol"},{"issue":"10","key":"4174_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","volume":"21","author":"DT Utzschneider","year":"2020","unstructured":"Utzschneider DT, Gabriel SS, Chisanga D, Gloury R, Gubser PM, Vasanthakumar A et al (2020) Early precursor T cells establish and propagate T cell exhaustion in chronic infection. Nat Immunol 21(10):1256\u20131266. https:\/\/doi.org\/10.1038\/s41590-020-0760-z","journal-title":"Nat Immunol"},{"issue":"12","key":"4174_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"Y-R Yu","year":"2020","unstructured":"Yu Y-R, Imrichova H, Wang H, Chao T, Xiao Z, Gao M et al (2020) Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nat Immunol 21(12):1540\u20131551. https:\/\/doi.org\/10.1038\/s41590-020-0793-3","journal-title":"Nat Immunol"},{"issue":"8","key":"4174_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41590-025-02219-2","volume":"26","author":"SKM Wijesinghe","year":"2025","unstructured":"Wijesinghe SKM, Rausch L, Gabriel SS, Galletti G, De Luca M, Qin L et al (2025) Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity. Nat Immunol 26(8):1367\u20131383. https:\/\/doi.org\/10.1038\/s41590-025-02219-2","journal-title":"Nat Immunol"},{"issue":"24","key":"4174_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155476","volume":"131","author":"JM Rae","year":"2021","unstructured":"Rae JM, Lippman ME (2021) The role of estrogen receptor signaling in suppressing the immune response to cancer. J Clin Invest 131(24):e155476. https:\/\/doi.org\/10.1172\/JCI155476","journal-title":"J Clin Invest"},{"issue":"2","key":"4174_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/ijms19020611","volume":"19","author":"N Rothenberger","year":"2018","unstructured":"Rothenberger N, Somasundaram A, Stabile L (2018) The role of the estrogen pathway in the tumor microenvironment. IJMS 19(2):611. https:\/\/doi.org\/10.3390\/ijms19020611","journal-title":"IJMS"},{"key":"4174_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.582863","volume":"10","author":"C Shuai","year":"2020","unstructured":"Shuai C, Yang X, Pan H, Han W (2020) Estrogen receptor downregulates expression of PD-1\/PD-L1 and infiltration of CD8+ T cells by inhibiting IL-17 signaling transduction in breast cancer. Front Oncol 10:582863. https:\/\/doi.org\/10.3389\/fonc.2020.582863","journal-title":"Front Oncol"},{"key":"4174_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674192","volume":"12","author":"J Goldberg","year":"2021","unstructured":"Goldberg J, Pastorello RG, Vallius T, Davis J, Cui YX, Agudo J et al (2021) The immunology of hormone receptor positive breast cancer. Front Immunol 12:674192. https:\/\/doi.org\/10.3389\/fimmu.2021.674192","journal-title":"Front Immunol"},{"issue":"7","key":"4174_CR29","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","volume":"18","author":"N Dumauthioz","year":"2021","unstructured":"Dumauthioz N, Tschumi B, Wenes M, Marti B, Wang H, Franco F et al (2021) Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity. Cell Mol Immunol 18(7):1761\u20131771. https:\/\/doi.org\/10.1038\/s41423-020-0365-3","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"4174_CR30","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, Xie Y-Q, Gao M, Zhao Y, Franco F, Wenes M et al (2021) Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. Nat Immunol 22(6):746\u2013756. https:\/\/doi.org\/10.1038\/s41590-021-00940-2","journal-title":"Nat Immunol"},{"issue":"23","key":"4174_CR31","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","volume":"187","author":"JG Baldwin","year":"2024","unstructured":"Baldwin JG, Heuser-Loy C, Saha T, Schelker RC, Slavkovic-Lukic D, Strieder N et al (2024) Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell 187(23):6614\u201330.e21. https:\/\/doi.org\/10.1016\/j.cell.2024.08.029","journal-title":"Cell"},{"issue":"2","key":"4174_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010430","volume":"13","author":"AC Garrido-Castro","year":"2025","unstructured":"Garrido-Castro AC, Graham N, Ali LR, Herold C, Desrosiers J, Do K et al (2025) Phase I study of ribociclib (CDK4\/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer. J Immunother Cancer 13(2):e010430. https:\/\/doi.org\/10.1136\/jitc-2024-010430","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4174_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/ijgc-2023-005189","volume":"34","author":"T Ottenbourgs","year":"2024","unstructured":"Ottenbourgs T, Van Gorp T, Kridelka F, Baert T, Denys H, Selle F et al (2024) A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial. Int J Gynecol Cancer 34(4):627\u2013630. https:\/\/doi.org\/10.1136\/ijgc-2023-005189","journal-title":"Int J Gynecol Cancer"},{"key":"4174_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117651","volume":"552","author":"K Gostomczyk","year":"2024","unstructured":"Gostomczyk K, \u0141ukaszewska E, Borowczak J, Bator A, Zdrenka M, Bodnar M, Szylberg \u0141 (2024) Flow cytometry in the detection of circulating tumor cells in neoplastic effusions. Clin Chim Acta 552:117651. https:\/\/doi.org\/10.1016\/j.cca.2023.117651","journal-title":"Clin Chim Acta"},{"key":"4174_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.570899","volume":"10","author":"W Shang","year":"2020","unstructured":"Shang W, Xu R, Xu T, Wu M, Xu J, Wang F (2020) Ovarian cancer cells promote glycolysis metabolism and TLR8-mediated metabolic control of human CD4+ T cells. Front Oncol 10:570899. https:\/\/doi.org\/10.3389\/fonc.2020.570899","journal-title":"Front Oncol"},{"issue":"3","key":"4174_CR36","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ygyno.2021.06.028","volume":"162","author":"B Werner","year":"2021","unstructured":"Werner B, Yuwono N, Duggan J, Liu D, David C, Srirangan S et al (2021) Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer. Gynecol Oncol 162(3):720\u2013727. https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.028","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4174_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1620","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang L, Li H, Zhang C, Chen Q, Liu Z, Zhang J et al (2024) Unlocking the potential of T-cell metabolism reprogramming: advancing single-cell approaches for precision immunotherapy in tumour immunity. Clin Transl Med 14(3):e1620. https:\/\/doi.org\/10.1002\/ctm2.1620","journal-title":"Clin Transl Med"},{"issue":"10","key":"4174_CR38","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/cancers15102845","volume":"15","author":"S Sch\u00fcler-Toprak","year":"2023","unstructured":"Sch\u00fcler-Toprak S, Skrzypczak M, Gr\u00fcndker C, Ortmann O, Treeck O (2023) Role of estrogen receptor \u03b2, G-protein coupled estrogen receptor and estrogen-related receptors in endometrial and ovarian cancer. Cancers 15(10):2845. https:\/\/doi.org\/10.3390\/cancers15102845","journal-title":"Cancers"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04174-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04174-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:09:16Z","timestamp":1760962156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04174-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4174"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04174-1","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University (NO.027(2021)).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"321"}}